2/28/2012

The FDA has granted Abbott expanded premarket approval for use of its Absolute Pro stent in treating patients with narrowed iliac arteries. The catheter-delivered device, which has been on the U.S. market since 2008 as a biliary stent, is also being marketed in more than 80 other countries.

Related Summaries